Showing results (121-130 of 283) with videos related to
Sort By:
Pageof 29
Canadian Journal of Physiology and Pharmacology|May 1, 1995
In vivo pharmacological evaluation of two novel type II (inducible) nitric oxide synthase inhibitorsW R Tracey, M Nakane, F Basha, et al.Brain Research. Developmental Brain Research|June 8, 1993
Developmental changes of cytosolic and particulate nitric oxide synthase in rat brainT Matsumoto, J S Pollock, M Nakane, et al.Brain Research|December 4, 1992
Evidence that nitric oxide mediates the cyclic GMP response to synaptic activity in the rat superior cervical ganglionH Sheng, M L Hughes, F Murad, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 1977
Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparationsW P Arnold, C K Mittal, S Katsuki, et al.Biochimica Et Biophysica Acta|March 9, 1990
Radiation inactivation target-size analysis of soluble guanylate cyclaseS Saheki, T Kuno, C Tanaka, et al.Biochimica Et Biophysica Acta|July 4, 1979
Synthesis of adenosine 3',5'-monophosphate by guanylate cyclase, a new pathway for its formationC K Mittal, J M Braughler, K Ichihara, et al.Biochemical Pharmacology|October 15, 1986
Desensitization to nitroglycerin in vascular smooth muscle from rat and humanS A Waldman, R M Rapoport, R Ginsburg, et al.European Journal of Pharmacology|February 13, 1992
Induced RAW 264.7 macrophages express soluble and particulate nitric oxide synthase: inhibition by transforming growth factor-betaU Förstermann, H H Schmidt, K L Kohlhaas, et al.European Journal of Pharmacology|May 13, 1986
Effects of atriopeptins on relaxation and cyclic GMP levels in human coronary artery in vitroR M Rapoport, R Ginsburg, S A Waldman, et al.British Journal of Pharmacology|January 1, 1996
Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cellsA Papapetropoulos, C Y Go, F Murad, et al.Pageof 29